Skip to main content

Table 1 Demographic characteristics of gout patients (N = 177,637)

From: Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population

  N %
Male gender 134,333 75.6%
Age in categories   
   20-49 59,371 33.4%
   50-59 54,612 30.7%
   60-69 37,016 20.8%
   70-79 19,790 11.1%
   80-89 6,848 3.9%
Comorbidities:   
Cardiometabolic 91,203 51.3%
   Congestive Heart Failure 7,467 4.2%
   Ischemic Heart Disease 18,066 10.2%
   Hypertension 64,094 36.1%
   Conduction and rhythm disorder 12,034 6.8%
   Cerebrovascular disease 4,934 2.8%
   Peripheral arterial disease 6,271 3.5%
   Chronic renal impairment 5,718 3.2%
   Dyslipidemia 47,960 27.0%
   Diabetes 26,818 15.1%
Gastrointestinal 14,224 8.0%
   Gastrointestinal 11,836 6.7%
   Hepatic disorders 2,718 1.5%
   Pancreatic disorders 501 0.3%
Haematological (Anemia) 3,829 2.2%
Myopathy 159 0.1%
Arthritis 25,516 14.4%
Osteoporosis 5,044 2.8%
   Any comorbidity 103,281 58.1%
Gout diagnosis recorded by:   
   Primary care physician 56,512 31.8%
   Rheumatologist 4,731 2.7%
   Emergency visit 10,482 5.9%
   Other or Unknown specialty 105,912 59.6%
Hospitalized in 12 months follow-up (at least once) 2,119 1.2%
Outpatient visit in 12 months follow-up (at least once) 65,665 37.0%
Number of flares in 12 months follow-up:   
   0 158,268 89.1%
   1 15,893 9.0%
   2 2,790 1.6%
   3 or more 686 0.4%